| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 2008 (ast)
- наукова стаття, опублікована у вересні 2008 (uk)
- مقالة علمية نشرت في سبتمبر 2008 (ar)
- scientific article published on September 2008 (en)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| cites work
| |
| cites work
| - Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 rheumatoid arthritis patients following leflunomide initiation
- Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire
- Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?
- Minimum important difference between patients with rheumatoid arthritis: the patient's perspective
- Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial
- Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis
- Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
- Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time
- Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability
- Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response
- Duration of rheumatoid arthritis influences the degree of functional improvement in clinical trials
- The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses
- Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration
- Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure
- Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy.
- Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects
|
| author name string
| |
| author name string
| - George Reed
- Joel M Kremer
- Dinesh Khanna
- David A Elashoff
- Daniel E Furst
- Harold E Paulus
- Veena K Ranganath
- Alina Onofrei
|
| rdfs:label
| - Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (nl)
- Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database. (en)
- Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database. (ast)
|
| skos:prefLabel
| - Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (nl)
- Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database. (en)
- Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database. (ast)
|
| name
| - Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (nl)
- Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database. (en)
- Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database. (ast)
|
| title
| |
| title
| - Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| PMCID
| |
| PMCID
| |
| is about
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)